VPIM
CVAC

Vanguard Personalized Indexing Management’s CureVac CVAC Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,358
Closed -$35.3K – 1860
2024
Q4 		$35.3K Sell
10,358
-27,583
-73% -$79.5K ﹤0.01% 1728
2024
Q3 		$112K Sell
37,941
-6,103
-14% -$20.1K ﹤0.01% 1598
2024
Q2 		$147K Buy
44,044
+21,999
+100% +$72K ﹤0.01% 1493
2024
Q1 		$66.8K Buy
22,045
+5,871
+36% +$20.6K ﹤0.01% 1552
2023
Q4 		$68.1K Buy
+16,174
New +$87.7K ﹤0.01% 1501

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Vanguard Personalized Indexing Management's CVAC Position: Q1 2025 in Review

Vanguard Personalized Indexing Management sold out of CureVac (CVAC) in Q1 2025, closing a stake of 10,358 shares — an estimated $35.3K sold.

Vanguard Personalized Indexing Management first reported a position in CVAC in Q4 2023 and held it in 5 quarters. The position peaked at $147K in Q2 2024. 83 funds tracked by Wall St. Rank hold CVAC as of Q1 2025.

  • Vanguard Personalized Indexing Management reported no remaining CureVac position as of Q1 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 10,358 CureVac shares in Q1 2025, an estimated $35.3K.
  • Vanguard Personalized Indexing Management first reported a position in CureVac in Q4 2023 and held it in 5 quarters.
  • Vanguard Personalized Indexing Management's CureVac position peaked at $147K in Q2 2024.
  • 83 funds tracked by Wall St. Rank held CureVac as of Q1 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2025, filed 14 May 2025.